Table 2.
S. no. | Name of the gene | Log2 fold change | |||
---|---|---|---|---|---|
Group A | Group B | ||||
RNA seq | qPCR | RNA seq | qPCR | ||
1 | FKBP5 | 2.91 | 2.97 | 4.47 | 3.94 |
2 | FST | − 2.45 | − 2.61 | − 2.04 | − 2.88 |
3 | MMP1 | − 1.97 | 0.30 | − 1.47 | − 4.53 |
4 | PDPN | 1.35 | 1.24 | − 0.001 | − 0.60 |
5 | PTK2B | 2.34 | 1.79 | 1.8 | 0.38 |
6 | RGCC | 4.79 | 3.54 | 3.59 | 4.48 |
7 | SERPINB2 | − 3.73 | − 2.10 | − 0.41 | 1.32 |
8 | VEGFC | − 1.32 | − 1.30 | − 0.82 | − 0.10 |
9 | ZBTB16 | 7.70 | 3.19 | 6.47 | 8.90 |
Group A: DEGs between DEX and ETH treated 16 h; Group B: DEGs between DEX and ETH treated for 7 d.
FKBP5 FK506 binding protein 5, FST follistatin, MMP1 matrix metalloproteinase-1, PDPN podoplanin; protein tyrosine kinase 2 beta, RGCC regulator of cell cycle, SERPINB2 serpin family B member 2, VEGFC vascular endothelial growth factor-C, ZBTB16 zinc finger and BTB domain containing 16.